Status:
UNKNOWN
Maternal and Fetal Adrenocorticotropic Hormone (ACTH) and Leukemia Inhibitory Factor (LIF) and Gestational Age
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Abortion, Legal
Eligibility:
FEMALE
18-44 years
Brief Summary
In 2010, Simamura et al have demonstrated in a rat model that one of the pro-inflammatory cytokine belonging to the Interleukin-6 family cytokines, LIF, is required for the proliferation of neuronal p...
Detailed Description
Study protocol: In the current study, the investigators will take fetal and maternal blood samples of fetuses undergoing termination of pregnancy (TOP) . Maternal samples will be acquired with the ro...
Eligibility Criteria
Inclusion
- Pregnant women undergoing termination of pregnancy in various gestational weeks.
- Pregnant women undergoing spontaneous abortion.
Exclusion
- •Intrauterine fetal death.
Key Trial Info
Start Date :
August 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03231904
Start Date
August 10 2017
End Date
December 31 2017
Last Update
August 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.